P53, CK20, and FGFR3 Overexpression is Associated with the Characteristics of Urothelial Cell Carcinoma of the Bladder

Volume 24, Issue 9, September 2023, Pages 3125-3131

Mojgan Asgari; Faezeh Firouzi; Maryam Abolhasani; Mohammad Bahadoram; Maedeh Barahman; Zahra Madjd; Mitra Mehrazam; Shakiba Hassanzadeh; Esma'il Akade

• View Article
• PDF 1.05 M

Detection of Epithelial-Mesenchymal Transition Markers in High Grade Bladder Cancer and Special Variants of Urothelial Carcinoma

Volume 23, Issue 6, June 2022, Pages 2079-2087

Heba Khalil; Olfat Ali Hammam; Amira Kamel

• View Article
• PDF 1.86 M

Histopathologic Evolution of Urothelial Carcinoma Recurrence in Transurethral Resection of the Urinary Bladder:35 Consecutive Cases And Literature Review

Volume 18, Issue 2, February 2017, Pages 459-463

Ali Koyuncuer

• View Article
• PDF 771.13 K

Application of a Network Scale-up Method to Estimate the Size of Population of Breast, Ovarian/Cervical, Prostate and Bladder Cancers

Volume 16, Issue 8, August 2015, Pages 3273-3277

• View Article
• PDF 353.08 K

Gemcitabine Plus Nedaplatin as Salvage Therapy is a Favorable Option for Patients with Progressive Metastatic Urothelial Carcinoma After Two Lines of Chemotherapy

Volume 16, Issue 6, June 2015, Pages 2483-2487

• View Article
• PDF 481.99 K

High Expression Level of Preoperative Serum Uroplakin III is Associated with Biologically Aggressive Bladder Cancer.

Volume 16, Issue 4, April 2015, Pages 1539-1543

• View Article
• PDF 526.33 K